CLYM

Climb Bio, Inc. - Common Stock

$1.95

Price of Climb Bio, Inc. stock today

The current price of CLYM is $1.95, with a market capitalization of $131.5. CLYM shares are listed on the NASDAQ stock exchange.

About Climb Bio, Inc.

Climb Bio Inc. is a clinical-stage biotechnology company developing therapeutics for patients with immune-mediated diseases. The Company's lead product candidate, budoprutug, is an anti-CD19 monoclonal antibody which has demonstrated B-cell depletion and has potential to treat a broad range of B-cell mediated diseases. Climb Bio Inc., formerly known as Eliem Therapeutics Inc., is based in WELLESLEY, Mass.

!Ups! Sometimes wrong

Try again

Key Stats

Analyst Recommendations

Frequently Asked Questions (FAQ)

1
Sign up on Hapi

Download the Hapi app from Google Playstore or the App Store, or from the website. Sign up by completing all the steps of the form and verify your identity.

2
Add funds to your Hapi account

Make an initial deposit to your account. There are no minimum amounts, allowing you to start with any amount.

3
Choose how much to invest in stocks

Use the search function in Hapi to find your favorite stocks. Then select "Buy", review the price, and confirm your purchase.

4
Manage all your investments in one place

Access your portfolio through the Hapi app or web version and monitor the performance of your stocks. You can easily buy and sell your stocks whenever you want.

Categories

Similar assets

News

¡Ups! Algo salió mal

Hubo un problema al cargar la información.
Verifica tu conexión e inténtalo nuevamente.

Volver a intentar

Invest from $5 USD

Join over 600,000 investors on Hapi.

Invierte desde $5 USD

Empezar a invertir